Antimicrobial Agents and Resistance

AARAntimicrobial Agents and Resistance (AAR) – formerly part of the Antimicrobial Agents and Infectious Diseases track – will cover a range of important topics. One of the major challenges today is the rising tide of antimicrobial resistance, with the emergence of "untreatable" microbes causing diseases that were once readily treatable. The AAR track is the best place to find information regarding new antimicrobial agent discovery, preclinical investigations of new antimicrobial drugs in the pipeline, and first-look data of human clinical trials using new antimicrobial agents. 


AAR01: Surveillance of Antimicrobial Resistance: Molecular Typing, Clinical and Molecular Epidemiology

AAR02: Antimicrobial Agents: Mechanisms of Action and Mechanisms of Resistance 

AAR03: Antifungal Agents and Resistance 

AAR04: Antimicrobial Pharmacokinetics, Pharmacodynamics and General Pharmacology 

AAR05: Antimicrobial Stewardship, including Quality of Care

AAR06: Antiviral Agents (including HIV Drugs) and Resistance 

AAR07: Experimental Therapeutics

AAR08: New Antimicrobial Agents (Pre-US IND or Prior to the Start of Clinical Therapeutic Studies/pre-phase 2) and New Research Technologies 

AAR09: Pharmacological Studies of Antimicrobial Agents Pre-NDA  


Hear from Top Speakers

Mel Spigelman
TB Alliance
Hiroshi Nikaido
University of California Berkeley 
Audrey Schuetz
Mayo Clinic
Jean-Marc Rolain
Aix-Marseille Université

See who is speaking. SEARCH ALL SPEAKERS IN TRACK.

Attend Innovative Sessions

Riddles and Rules of Gram-negative Permeation
June 8, 2018 • 1:30 p.m. – 2:15 p.m. 


RegisterNow blue